MidCap Financial Investment (MFIC) stock price is $10.18, unchanged on the day, as of Nov 13, 2026. It has a market cap of $838.55Mn, and is classified in the Business Development Companies industry (Financial Services sector).
Enterprise Value
Margins
P/FCF
Key Stats
Market Cap838.55 Mn
P/E-11.40
FCF (Yr)-49.75 Mn
ROA (Yr)–
EV to EBIT–
Net Income (Yr)63.17 Mn
Enterprise Value597.08 Mn
Add ratio to table…
About
MidCap Financial Investment Corporation is a closed end externally managed diversified management investment company. It has elected to be treated as a business development company under the Investment Company Act of 1940. For tax purposes it has elected to be treated as a regulated investment company under Subchapter M of the Internal Revenue Code. The company’s investment objective is to generate current income and to a lesser extent long term capital appreciation. It…
MidCap Financial Investment Corporation is a closed end externally managed diversified management investment company. It has elected to be treated as a business development company under the Investment Company Act of 1940. For tax purposes it has elected to be treated as a regulated investment company under Subchapter M of the Internal Revenue Code. The company’s investment objective is to generate current income and to a lesser extent long term capital appreciation. It primarily originates and negotiates first lien senior secured loans to privately held United States middle market companies defined generally as businesses with less than seventy five million dollars of EBITDA. To a lesser extent it also invests in first lien unitranche loans second lien senior secured loans unsecured loans subordinated and mezzanine loans and equity interests such as common stock preferred stock warrants or options. The portfolio consists mainly of debt investments in private middle market companies with aggregate tranche sizes typically under three hundred million dollars. Most of the debt instruments are unrated or rated below investment grade reflecting their speculative nature. As of December 31 2025 the portfolio comprised 247 companies with 95 percent in secured debt zero percent in unsecured debt zero percent in structured products one percent in preferred equity and four percent in common equity interests and warrants. Since its inception the firm has deployed approximately twenty six point eight billion dollars across 848 portfolio companies and has transacted with more than one hundred different financial sponsors.
The company generates revenue principally from interest payments on its debt securities and dividend distributions on its equity holdings. The weighted average yield on the secured debt portfolio was 9.7 percent as of December 31 2025 while the unsecured debt portfolio yielded 11.1 percent and the total debt portfolio yielded 9.7 percent. The overall portfolio yield stood at 8.6 percent on a cost basis at the same date. These yields reflect the interest income earned from loans and other debt instruments held in the portfolio. In addition the company receives dividend income from its preferred and common equity positions as well as from warrants that may be exercised. Realized capital gains from the sale or repayment of investments also contribute to earnings as evidenced by the 1.1 billion dollars of investments sold or repaid during the year ended December 31 2025. The firm’s total return which combines price appreciation and reinvested dividends was minus 4.3 percent for the fiscal year ended December 31 2025. Management and advisory fees paid to the investment adviser are expenses not sources of revenue. Overall the revenue stream is driven by the cash flow generated from the loan book and the occasional realization of gains from portfolio turnover.
MidCap Financial Investment Corporation operates in the highly competitive specialty finance sector that provides capital to middle market businesses. Its primary competitors include public and private investment funds commercial and investment banks commercial finance companies other business development companies hedge funds and private equity funds. Many of these rivals possess greater scale lower cost of funds and broader access to capital sources that are not available to the company. Despite these disadvantages MidCap benefits from its affiliation with Apollo Global Management which supplies deep industry knowledge extensive research capabilities and a long track record in credit investing. The investment adviser draws on Apollo’s thirty year history and its network of professionals across more than two hundred companies. The firm also holds an exemptive order from the Securities and Exchange Commission that permits coinvestment with other Apollo managed funds subject to specific conditions enhancing its ability to participate in larger deals. Its status as a business development company and a regulated investment company delivers a tax efficient structure that passes through income to shareholders and imposes regulatory discipline on leverage and diversification. The company’s strategy focuses on directly originated privately negotiated senior secured loans with floating rate terms which helps insulate the portfolio from interest rate volatility. As of December 31 2025 one hundred percent of the direct origination portfolio consisted of floating rate debt measured at fair value. This combination of proprietary sourcing disciplined underwriting and access to Apollo’s platform gives MidCap a distinct niche within the middle market lending landscape.
The company’s capital is supplied by public and private investors who purchase its shares on the open market or through private placements. These shareholders seek regular income and potential capital appreciation from a professionally managed portfolio of middle market debt and equity investments. On the other side of the balance sheet the firm extends financing to privately held United States middle market companies across a wide range of industries including software health care consumer services manufacturing and financial services. The borrowers use the proceeds to support operations fund acquisitions refinance existing debt or pursue growth initiatives. While the filing does not disclose the names of individual shareholders or portfolio companies the investor base consists of institutional accounts retail holders and advisory platforms that value the firm’s focus on yield. The borrower base comprises entrepreneurial owned businesses and sponsor backed enterprises that typically generate positive cash flows and possess asset coverage sufficient to support senior secured lending.
Sector:Financial ServicesSector rationaleThe company operates as a Business Development Company (BDC) that generates revenue primarily from interest payments on senior secured loans and dividend distributions from equity holdings. Its core business is the origination and management of debt and equity investments for middle-market companies, which falls directly under Specialty Finance within the Financial Services sector.Industry:Business Development CompaniesBusiness Development CompaniesPrimaryThe company explicitly states it has elected to be treated as a business development company (BDC) under the Investment Company Act of 1940. Its core activity is originating and holding first lien senior secured loans and equity interests in private middle-market companies.Classified using BQ-MICSCIK: 0001278752
Bull & bear
Investment Thesis
▲ Bull case
MidCap Financial Investment Corporation is positioned to capitalize on a significant undervaluation of its high-quality investment portfolio, which management believes does not reflect intrinsic value due to persistent market discounts. The company's strategy of aggressively utilizing its $100 million share repurchase authorization, combined with remaining capacity of $107.9 million, creates a powerful catalyst for shareholder value creation. By repurchasing shares at an average 18% discount to NAV—directly accretive to NAV per share—management is effectively deploying capital at a return that exceeds what could be earned from new investments in the current spread-compressed environment. This approach leverages the company's strong liquidity position and visibility into expected repayments, such as the ongoing Merx wind-down, to enhance NAV per share without materially increasing net leverage. The disciplined execution of this buyback program, supported by a 10b5-1 plan to maintain activity during quiet periods, signals confidence in the underlying asset quality and provides a tangible floor for the stock price while the market reevaluates the portfolio's resilience.
The company's direct origination portfolio maintains structural strengths that are underappreciated by the market, particularly its heavy weighting toward first lien loans (99%) and financial sponsor backing (92%), which provide superior downside protection in a volatile credit environment. Despite near-term headwinds from lower base rates and spread compression, the portfolio's interest coverage ratio improved sequentially from 2.2x to 2.3x, indicating underlying borrower resilience driven by earnings growth and reduced financing costs. Additionally, the software exposure—often perceived as a risk—is actually a conservative allocation at just 11.4% of the portfolio, characterized by low average loan-to-value (32%), high covenant penetration (90%), and mission-critical borrowers with strong revenue visibility from long-term contracts. This software book is not exposed to the high-leverage, ARR-dependent models that dominate broader market fears; instead, it consists of cash-flow stable companies with average net leverage of 4.6x and interest coverage of 2.3x, in line with the total portfolio. These attributes suggest the software segment is a stabilizing, not a speculative, component of the portfolio, and its conservative underwriting may outperform if broader software credit stresses materialize.
The ongoing resolution of legacy non-accrual positions, exemplified by the Merx wind-down and Compass Health restructuring, represents a hidden catalyst for future income recovery and NAV stabilization that is not fully reflected in current guidance. Merx exposure, which totaled $103 million at fair value (3% of portfolio) at quarter end, has already seen $22 million repaid post-quarter, bringing total repayments to $29.5 million, with the remaining balance consisting of four aircraft and a servicing platform generating remarketing fees from Navigator. This orderly liquidation is expected to return capital at or above book value over the next 12 months, providing a meaningful tailwind to investment income as these funds are recycled into new originations or used to support the dividend and buyback program. Similarly, the recovery on Compass Health—where a net gain of approximately $1 million was recognized in the quarter with an additional $0.5 million expected—demonstrates the company's ability to extract value from challenged credits through active management. These vintage-specific resolutions, particularly from 2022 and earlier vintages that drove the NAV decline, are expected to reduce future non-accrual drag and improve portfolio seasoning, turning a current headwind into a future source of alpha as the portfolio's credit quality improves through workout successes.
MidCap Financial Investment Corporation is positioned to capitalize on a significant undervaluation of its high-quality investment portfolio, which management believes does not reflect intrinsic value due to persistent market discounts. The company's strategy of aggressively utilizing its $100 million share repurchase authorization, combined with remaining capacity of $107.9 million, creates a powerful catalyst for shareholder value creation. By repurchasing shares at an average 18% discount to NAV—directly accretive to NAV per share—management is effectively deploying capital at a return that exceeds what could be earned from new investments in the current spread-compressed environment. This approach leverages the company's strong liquidity position and visibility into expected repayments, such as the ongoing Merx wind-down, to enhance NAV per share without materially increasing net leverage. The disciplined execution of this buyback program, supported by a 10b5-1 plan to maintain activity during quiet periods, signals confidence in the underlying asset quality and provides a tangible floor for the stock price while the market reevaluates the portfolio's resilience.
The company's direct origination portfolio maintains structural strengths that are underappreciated by the market, particularly its heavy weighting toward first lien loans (99%) and financial sponsor backing (92%), which provide superior downside protection in a volatile credit environment. Despite near-term headwinds from lower base rates and spread compression, the portfolio's interest coverage ratio improved sequentially from 2.2x to 2.3x, indicating underlying borrower resilience driven by earnings growth and reduced financing costs. Additionally, the software exposure—often perceived as a risk—is actually a conservative allocation at just 11.4% of the portfolio, characterized by low average loan-to-value (32%), high covenant penetration (90%), and mission-critical borrowers with strong revenue visibility from long-term contracts. This software book is not exposed to the high-leverage, ARR-dependent models that dominate broader market fears; instead, it consists of cash-flow stable companies with average net leverage of 4.6x and interest coverage of 2.3x, in line with the total portfolio. These attributes suggest the software segment is a stabilizing, not a speculative, component of the portfolio, and its conservative underwriting may outperform if broader software credit stresses materialize.
The ongoing resolution of legacy non-accrual positions, exemplified by the Merx wind-down and Compass Health restructuring, represents a hidden catalyst for future income recovery and NAV stabilization that is not fully reflected in current guidance. Merx exposure, which totaled $103 million at fair value (3% of portfolio) at quarter end, has already seen $22 million repaid post-quarter, bringing total repayments to $29.5 million, with the remaining balance consisting of four aircraft and a servicing platform generating remarketing fees from Navigator. This orderly liquidation is expected to return capital at or above book value over the next 12 months, providing a meaningful tailwind to investment income as these funds are recycled into new originations or used to support the dividend and buyback program. Similarly, the recovery on Compass Health—where a net gain of approximately $1 million was recognized in the quarter with an additional $0.5 million expected—demonstrates the company's ability to extract value from challenged credits through active management. These vintage-specific resolutions, particularly from 2022 and earlier vintages that drove the NAV decline, are expected to reduce future non-accrual drag and improve portfolio seasoning, turning a current headwind into a future source of alpha as the portfolio's credit quality improves through workout successes.
MidCap Financial Investment Corporation faces persistent and potentially structural headwinds from lower base rates and asset spread compression that are eroding its core earnings power, with management's dividend cut to $0.31 per share reflecting a fundamental reassessment of long-term earning capacity that may not be reversible. The 5.1% quarter-over-quarter decline in total investment income, driven by decreased base rates, new non-accruals, and spread compression, is not merely cyclical but indicative of a prolonged low-rate environment that is squeezing net interest margins across the BDC sector. Despite refinancing that lowered the cost of debt to 5.95%, the weighted average yield at cost on the direct origination portfolio fell to 10% from 10.3%, signaling that the reinvestment yield on new loans is structurally impaired. This dynamic threatens the sustainability of the current dividend level, as the company's ability to generate sufficient net investment income to cover distributions is increasingly challenged, and further reductions may be necessary if base rates remain subdued or spreads continue to tighten, undermining the income-focused investment thesis that attracts many BDC investors.
The company's portfolio continues to suffer from unresolved credit weaknesses in older vintages, with the 3.3% sequential NAV decline driven predominantly by 2022 and earlier investments that management acknowledges as the primary source of valuation pressure. The placement of three new non-accruals—Bird Rides, Banner Solutions, and Renovo—accounting for 36% of the quarter's net loss reveals ongoing credit deterioration that is not being offset by new originations or recoveries at a sufficient pace. While some challenged credits like Compass Health and LendingPoint have shown improvement, the net increase in non-accrual-related losses suggests that the portfolio's seasoning is exposing latent risks from underwriting during a period of looser credit standards, and these vintage-specific issues may persist longer than anticipated due to idiosyncratic factors such as poorly integrated acquisitions or aggressive growth strategies that are resistant to macroeconomic improvement. This ongoing drag from legacy assets could continue to suppress NAV growth and divert management resources from new investments, creating a persistent overhang that contradicts the narrative of a rapidly improving portfolio.
MidCap Financial Investment Corporation's aggressive share repurchase strategy, while accretive in the short term, risks exacerbating long-term financial flexibility and may signal a lack of compelling internal investment opportunities, raising concerns about the company's growth trajectory in a competitive middle-market lending landscape. The decision to prioritize buybacks over new investments—despite $141 million in commitments during the quarter—implies that management views external deployment as less accretive than repurchasing at an 18% discount to NAV, which could reflect either genuine undervaluation or a dearth of attractive, risk-adjusted lending opportunities in the current market. If the discount persists due to fundamental concerns about earnings power or credit quality rather than temporary market inefficiency, the buyback program could become a capital return mechanism that slowly shrinks the balance sheet without addressing the root causes of the discount. Furthermore, the increased reliance on buybacks to support the stock price may distract from necessary portfolio reforms or credit remediation efforts, particularly if the underlying issue is not market mispricing but rather a structural decline in the quality or yield of the originated loan book that buybacks cannot remedy.
MidCap Financial Investment Corporation faces persistent and potentially structural headwinds from lower base rates and asset spread compression that are eroding its core earnings power, with management's dividend cut to $0.31 per share reflecting a fundamental reassessment of long-term earning capacity that may not be reversible. The 5.1% quarter-over-quarter decline in total investment income, driven by decreased base rates, new non-accruals, and spread compression, is not merely cyclical but indicative of a prolonged low-rate environment that is squeezing net interest margins across the BDC sector. Despite refinancing that lowered the cost of debt to 5.95%, the weighted average yield at cost on the direct origination portfolio fell to 10% from 10.3%, signaling that the reinvestment yield on new loans is structurally impaired. This dynamic threatens the sustainability of the current dividend level, as the company's ability to generate sufficient net investment income to cover distributions is increasingly challenged, and further reductions may be necessary if base rates remain subdued or spreads continue to tighten, undermining the income-focused investment thesis that attracts many BDC investors.
The company's portfolio continues to suffer from unresolved credit weaknesses in older vintages, with the 3.3% sequential NAV decline driven predominantly by 2022 and earlier investments that management acknowledges as the primary source of valuation pressure. The placement of three new non-accruals—Bird Rides, Banner Solutions, and Renovo—accounting for 36% of the quarter's net loss reveals ongoing credit deterioration that is not being offset by new originations or recoveries at a sufficient pace. While some challenged credits like Compass Health and LendingPoint have shown improvement, the net increase in non-accrual-related losses suggests that the portfolio's seasoning is exposing latent risks from underwriting during a period of looser credit standards, and these vintage-specific issues may persist longer than anticipated due to idiosyncratic factors such as poorly integrated acquisitions or aggressive growth strategies that are resistant to macroeconomic improvement. This ongoing drag from legacy assets could continue to suppress NAV growth and divert management resources from new investments, creating a persistent overhang that contradicts the narrative of a rapidly improving portfolio.
MidCap Financial Investment Corporation's aggressive share repurchase strategy, while accretive in the short term, risks exacerbating long-term financial flexibility and may signal a lack of compelling internal investment opportunities, raising concerns about the company's growth trajectory in a competitive middle-market lending landscape. The decision to prioritize buybacks over new investments—despite $141 million in commitments during the quarter—implies that management views external deployment as less accretive than repurchasing at an 18% discount to NAV, which could reflect either genuine undervaluation or a dearth of attractive, risk-adjusted lending opportunities in the current market. If the discount persists due to fundamental concerns about earnings power or credit quality rather than temporary market inefficiency, the buyback program could become a capital return mechanism that slowly shrinks the balance sheet without addressing the root causes of the discount. Furthermore, the increased reliance on buybacks to support the stock price may distract from necessary portfolio reforms or credit remediation efforts, particularly if the underlying issue is not market mispricing but rather a structural decline in the quality or yield of the originated loan book that buybacks cannot remedy.